Dabrafenib
CAS Registry Number: 1195765-45-7
Anticancer
USP
EP
BP
IUPAC Name
N-[3-[5-(2-aminopyrimidin-4-yl)-2-tert-butyl-1,3-thiazol-4-yl]-2-fluorophenyl]-2,6-difluorobenzenesulfonamide
Dabrafenib is a anticancer agent available from Saarv Biochem in pharmacopoeia-grade quality.
Contact us for detailed specifications, certificates of analysis, and regulatory documentation.
Available Documentation
Certificate of Analysis
Available on request
Impurity Profile
Available on request
Stability Data
Available on request
DMF Support
Available on request
CoA (Batch-wise)
Available on request
Regulatory Filing
Case by case
Request a Quote
Fill in your requirements and we'll respond with pricing and availability within 24 hours.